Back

T cell tolerant fraction as a predictor of graft-vs-host disease following allogeneic hematopoietic cell transplantation

2025-11-10 transplantation Title + abstract only
View on medRxiv
Show abstract

BackgroundDonor T cell reconstitution following allogeneic hematopoietic cell transplantation (HCT) is crucial for protective immunity against infections and cancer relapse. However, its use remains limited by the risk of graft-versus-host disease (GvHD), a serious complication arising when donor T cells target recipient tissues. Here we evaluate a novel metric--the T cell receptor beta (TRB) tolerant fraction--as a predictor of GvHD risk. MethodsWe analyzed TRB sequencing data from mouse model...

Predicted journal destinations